A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study

被引:8
|
作者
Liu, Qiling [1 ,2 ]
Zhao, Gang [3 ]
Li, Qian [4 ]
Wu, Weiyun [5 ]
Zhang, Yan [6 ]
Bian, Hua [1 ,2 ,6 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China
[2] Fudan Univ, Fudan Inst Metab Dis, Shanghai, Peoples R China
[3] Fudan Univ, Wusong Branch, Hlth Examinat Ctr, Zhongshan Hosp, Shanghai, Peoples R China
[4] Fudan Univ, Wusong Branch, Clin Lab, Zhongshan Hosp, Shanghai, Peoples R China
[5] Fudan Univ, Zhongshan Hosp, Clin Lab, Shanghai, Peoples R China
[6] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Wusong Branch, Shanghai, Peoples R China
关键词
Fatty liver; Metabolic dysfunction-associated fatty liver disease; Nonalcoholic fatty liver disease; Diagnosis; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; FIBROSIS; OBESITY; ACIDS; RISK; NASH;
D O I
10.1186/s12876-022-02576-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background A recently proposed diagnostic criteria of metabolic dysfunction-associated fatty liver disease (MAFLD) is more available for various clinical situations than nonalcoholic fatty liver disease (NAFLD), but understanding about differences between NAFLD and MAFLD in clinical practice remains limited in the general adult urban population in China. Methods A total of 795 subjects were recruited from Wu Song Branch of Zhongshan Hospital who participated in the general health assessment. Examination results was obtained through analysis of blood samples and abdominal ultrasonography. Participants were divided into four subgroups according to whether they had NAFLD or MAFLD (NAFLD- MAFLD-, NAFLD + MAFLD-, NAFLD- MAFLD + and NAFLD + MAFLD+). Results Among the urban healthy adults investigated, 345 people (43.4%) were diagnosed with NAFLD and 356 people (44.8%) with MAFLD. No significant differences in the prevalence, age, fasting blood glucose, glycosylated hemoglobin, liver enzyme examination, percentage of overweight, hypertension or dyslipidaemia were found between NAFLD and MAFLD patients. Patients with MAFLD had worse metabolic disorders than NAFLD + MAFLD- patients. The NAFLD fibrosis score (NFS) of the NAFLD- MAFLD + group was higher than that of the NAFLD + MAFLD- group. Higher proportion of patients in the NAFLD- MAFLD + group have NFS >=-1.455. Conclusion MAFLD criteria have similar prevalence and patient characteristics compared with previous NAFLD but help to identify a group of patients with high risks of metabolic disorders and liver fibrosis who have been missed with NAFLD, and has superior utility.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] A comparison of NAFLD and MAFLD diagnostic criteria in contemporary urban healthy adults in China: a cross-sectional study
    Qiling Liu
    Gang Zhao
    Qian Li
    Weiyun Wu
    Yan Zhang
    Hua Bian
    [J]. BMC Gastroenterology, 22
  • [2] Comparison of MAFLD and NAFLD diagnostic criteria in real world
    Lin, Su
    Huang, Jiaofeng
    Wang, Mingfang
    Kumar, Rahul
    Liu, Yuxiu
    Liu, Shiying
    Wu, Yinlian
    Wang, Xiaozhong
    Zhu, Yueyong
    [J]. LIVER INTERNATIONAL, 2020, 40 (09) : 2082 - 2089
  • [3] Prediction of MAFLD and NAFLD using different screening indexes: A cross-sectional study in US adults
    Peng, Hongye
    Pan, Liang
    Ran, Simiao
    Wang, Miyuan
    Huang, Shuxia
    Zhao, Mo
    Cao, Zhengmin
    Yao, Ziang
    Xu, Lei
    Yang, Qing
    Lv, Wenliang
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Response to: Comparison of MAFLD and NAFLD diagnostic criteria in real world
    Nguyen, Vy H.
    Le, Michael H.
    Henry, Linda
    Cheung, Ramsey
    [J]. LIVER INTERNATIONAL, 2020, 40 (12) : 3145 - 3145
  • [5] Novel MAFLD criteria identifies additional individual at risk for FIBROSIS: in depth comparison of MAFLD and NAFLD criteria in the Rotterdam Study
    van Kleef, Laurens
    Ayada, Ibrahim
    Pan, Qiuwei
    De Knegt, Robert
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S550 - S551
  • [6] Prevalence and risk factors of MAFLD and its metabolic comorbidities in community-based adults in China: A cross-sectional study
    He, Yajun
    Yao, Nanfang
    Tian, Feng
    Liu, Lingling
    Lin, Xu
    Chen, Xingying
    Duan, Hualin
    Jiang, Yuqi
    Yu, Genfeng
    Song, Cheng
    Wang, Dongmei
    Ma, Qintao
    Liu, Lan
    Wan, Heng
    Shen, Jie
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (03)
  • [7] Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
    Liu, Qingdan
    Han, Meilan
    Li, Meilan
    Huang, Xiaoyin
    Feng, Ruimei
    Li, Wanxin
    Chen, Jun
    He, Haiying
    Zheng, Wenxin
    Hu, Zhijian
    Du, Shanshan
    Ye, Weimin
    [J]. LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [8] Shift in prevalence and systemic inflammation levels from NAFLD to MAFLD: a population-based cross-sectional study
    Qingdan Liu
    Meilan Han
    Meilan Li
    Xiaoyin Huang
    Ruimei Feng
    Wanxin Li
    Jun Chen
    Haiying He
    Wenxin Zheng
    Zhijian Hu
    Shanshan Du
    Weimin Ye
    [J]. Lipids in Health and Disease, 22
  • [9] Adolescent health and Healthy China 2030: a cross-sectional study
    Dong, Bin
    Zou, Zhiyong
    Song, Yi
    Hu, Peijing
    Luo, Dongmei
    Wen, Bo
    Gao, Di
    Wang, Xijie
    Yang, Zhaogeng
    Ma, Yinghua
    Ma, Jun
    Tian, Xiaobo
    Huang, Xiaona
    Patton, George C.
    [J]. LANCET, 2018, 392 : 63 - 63
  • [10] Associations Between GGT/HDL and MAFLD: A Cross-Sectional Study
    Xing, Yuling
    Chen, Jinhu
    Liu, Jing
    Ma, Huijuan
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 383 - 394